CXApp Names Joy Mbanugo CFO-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

CXApp Names Joy Mbanugo CFO

Aug 19, 2024 10:24 AM

01:06 PM EDT, 08/19/2024 (MT Newswires) -- CXApp ( CXAI ) said Monday it has appointed Joy Mbanugo as chief financial officer, effective immediately.

The company said Mbanugo previously served as CFO at ServiceRocket.

Shares of CXApp ( CXAI ) were up 7.5% in recent trading.

Price: 2.45, Change: +0.17, Percent Change: +7.46

Previous page： Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday? Next page： Market Chatter: Boeing May Be Beneficiary of All Nippon Airlines Expansion Plans

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?

Jun 3, 2024

On Monday, Arrowhead Pharmaceuticals Inc ( ARWR ). released topline results from the Phase 3 PALISADE study of plozasiran in patients with genetically confirmed or clinically diagnosed familial chylomicronemia syndrome (FCS). FCS is a rare metabolic disease that prevents the body from digesting fats. Related: What Arrowhead Pharmaceutical’s Interim Data Reveals About A RNAi Therapeutic For Rare Cholesterol Disorder The...

Market Chatter: Boeing May Be Beneficiary of All Nippon Airlines Expansion Plans

Jun 3, 2024

01:52 PM EDT, 06/03/2024 (MT Newswires) -- While Boeing ( BA ) still has to deliver more than 50 aircraft to All Nippon Airlines, it could still receive more orders from the Japanese carrier as it expands international flights, Bloomberg said Monday, citing All Nippon chief executive Shinichi Inoue. The report did not explicitly mention Boeing ( BA ) or...

Update: Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate

Jun 3, 2024

01:56 PM EDT, 06/03/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) Intellia Therapeutics' ( NTLA ) shares rose 10% in recent Monday afternoon trading after the company said it observed a 98% mean reduction in monthly attack rate in the phase 1 portion of its ongoing phase 1/2 study of NTLA-2002. The study is...

Update: Market Chatter: EU Antitrust Regulators Unlikely to Seek Feedback on EEX-Nasdaq Deal Remedies

Jun 3, 2024

01:58 PM EDT, 06/03/2024 (MT Newswires) -- (Updates with EEX's response declining to comment in fourth paragraph.) The European Commission is unlikely to seek feedback to remedies the European Energy Exchange submitted to address antitrust concerns on EEX's acquisition of Nasdaq's (NDAQ) European power trading and clearing business, Reuters reported Monday. That signals the remedies are insufficient, the report said,...